Funding boost for GSK open lab
May 7, 2013Research and Development, Sales and Marketing GSK, Wellcome
GlaxoSmithKline has been given an extra £5 million by the Wellcome Trust to help support its work in Spain on …
Lessons from the business gurus
May 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, buffet, business gurus
Marketing books are full of pithy quotes from business gurus, quotes which are often repeated until they almost become mantras. …
FleishmanHillard appoints two directors
May 7, 2013Medical Communications, Sales and Marketing FleishmanHillard
Comms firm FleishmanHillard has added two directors to its Healthcare leadership team. Robert Hanvik and Alison Wright have joined the …
FDA approves Liptruzet
May 7, 2013Sales and Marketing FDA, Merck, liptruzet
Merck is celebrating after its once-daily anti-cholesterol pill Liptruzet was approved by US regulators, expanding its indications. The drug – …
Teva says US facility will close in cost-cutting drive
May 3, 2013Manufacturing and Production Teva, closure, cuts
Teva has said it will shut down a manufacturing and R&D facility in Pennsylvania by 2017, with the loss of …
Sanofi’s performance dives
May 3, 2013Sales and Marketing Q1, Sanofi
Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …
Sanofi appoints two executive members
May 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive
Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …
Lundbeck moves ahead in Q1
May 3, 2013Sales and Marketing Lexapro, Lundbeck, Otsuka, Q1
Lundbeck’s sales and profit increase in the first three months of 2013 was due largely to one-off payments it received, …
FDA seeks manufacturing data for GSK’s trametinib
May 2, 2013Manufacturing and Production FDA, GSK, melanoma
GlaxoSmithKline’s melanoma drug candidate trametinib has been delayed in the US by an FDA request for more information on its …
Boehringer and OBT in cancer tie-up
May 2, 2013Research and Development, Sales and Marketing Boehringer, Cancer, OBT
Boehringer Ingelheim and UK biotech firm Oxford BioTherapeutics (OBT) have signed a deal to discover novel antibody targets in cancer. …
Court rules against EMA disclosure
May 2, 2013Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Roche, transparency
The European Medicines Agency (EMA) has been ordered in an interim ruling by the General Court of the European Union …
Not-for-profit comms agency adds special advisor
May 1, 2013Medical Communications, Sales and Marketing Comprehensive communications
A new not-for-profit marketing and comms consultancy that specialises in healthcare and research has added Professor Martin Gibson to its …
GSK abandons Parkinson’s drug
May 1, 2013Research and Development, Sales and Marketing GSK, IPX066, Parkinson's
GlaxoSmithKline has terminated its three-year old agreement with Impax Pharmaceuticals to develop investigational Parkinson’s disease drug IPX066. “The decision has …
Manufacturing issues block Gilead approvals
May 1, 2013Manufacturing and Production FDA, Gilead
The FDA has blocked approval of two of Gilead Sciences’ HIV drugs because of deficiencies in their marketing applications related …
Life appoints new executive
May 1, 2013Medical Communications, Sales and Marketing Anderson, Life
Creative comms agency Life Healthcare Communications has appointed a new account executive as part of the expansion of its client …
Charity: MS treatment is ‘lottery’
May 1, 2013Sales and Marketing MS, lottery, society
Multiple sclerosis care in the UK is a ‘lottery’ according to research by the MS Society. The charity says that …
Pfizer sales shrink 9 per cent
April 30, 2013Sales and Marketing Ian Read, Lipitor, Pfizer
Pfizer endured another painful cut to its revenues in the first quarter of 2013, with sales down $1.4 billion, or …
Pfizer and Merck create major diabetes alliance
April 30, 2013Research and Development, Sales and Marketing Merck, Pfizer, diabetes
Pfizer and Merck have unveiled a major new alliance in diabetes which is likely to raise the stakes in the …
AstraZeneca backs online NHS passport tool
April 30, 2013Medical Communications, Sales and Marketing NHS, NIHR, app, medication passport
AstraZeneca has provided support to an NHS partner launching an online tool to help patients keep track of their health …
‘Solid’ start for Novartis
April 30, 2013Sales and Marketing Novartis, Q1, sales
Novartis’ sales of pharma products were unchanged in the first quarter of 2013 at $7.9 billion, with pricing flat, the …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
